Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_assertion type Assertion NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_head.
- NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_assertion description "[However, the presence of p53 mutations in skin premalignant lesions suggests that these represent early events during tumor progression and additional alterations may be required for SCC development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_provenance.
- NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_assertion evidence source_evidence_literature NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_provenance.
- NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_assertion SIO_000772 25639555 NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_provenance.
- NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_assertion wasDerivedFrom befree-2016 NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_provenance.
- NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_assertion wasGeneratedBy ECO_0000203 NP1259919.RAzTZKllHZ9toX7h69FcJ3em268-HVnlaYw621-fHX5Mo130_provenance.